{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T15:16:29Z","timestamp":1759331789374},"reference-count":27,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2014,2,1]],"date-time":"2014-02-01T00:00:00Z","timestamp":1391212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Grant-in-Aid for Scientific Research of Japan","award":["23590433","23590432"],"award-info":[{"award-number":["23590433","23590432"]}]}],"content-domain":{"domain":["lungcancerjournal.info","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Lung Cancer"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1016\/j.lungcan.2013.10.018","type":"journal-article","created":{"date-parts":[[2013,11,13]],"date-time":"2013-11-13T09:03:11Z","timestamp":1384333391000},"page":"139-145","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Activation of Akt involves resistance to NF-\u03baB inhibition and abrogation of both triggers synergistic apoptosis in lung adenocarcinoma cells"],"prefix":"10.1016","volume":"83","author":[{"given":"Tomiteru","family":"Togano","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariko","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kinji","family":"Itoh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuo","family":"Umezawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noriyuki","family":"Masuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaaki","family":"Higashihara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryouichi","family":"Horie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl 2","key":"10.1016\/j.lungcan.2013.10.018_bib0005","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1038\/sj.bjc.6602062","article-title":"Treatment of non-small-cell lung cancer: a perspective on the recent advances and the experience with gefitinib","volume":"91","author":"Onn","year":"2004","journal-title":"Br J Cancer"},{"key":"10.1016\/j.lungcan.2013.10.018_bib0010","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1002\/emmm.201100176","article-title":"Oncogene addiction as a foundational rationale for targeted anti-cancer therapy: promises and perils","volume":"3","author":"Torti","year":"2011","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.lungcan.2013.10.018_bib0015","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1056\/NEJMoa040938","article-title":"Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib","volume":"350","author":"Lynch","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lungcan.2013.10.018_bib0020","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1126\/science.1099314","article-title":"EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy","volume":"304","author":"Paez","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.lungcan.2013.10.018_bib0025","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/nature05945","article-title":"Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer","volume":"448","author":"Soda","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.lungcan.2013.10.018_bib0030","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1586\/era.13.18","article-title":"Anaplastic lymphoma kinase: a glimmer of hope in lung cancer treatment","volume":"13","author":"Franco","year":"2013","journal-title":"Expert Rev Anticancer Ther"},{"key":"10.1016\/j.lungcan.2013.10.018_bib0035","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/ni0302-221","article-title":"NF-kappaB at the crossroads of life and death","volume":"3","author":"Karin","year":"2002","journal-title":"Nat Immunol"},{"key":"10.1016\/j.lungcan.2013.10.018_bib0040","doi-asserted-by":"crossref","first-page":"a000109","DOI":"10.1101\/cshperspect.a000109","article-title":"Oncogenic activation of NF-kappaB","volume":"2","author":"Staudt","year":"2010","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"10.1016\/j.lungcan.2013.10.018_bib0045","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/nature08462","article-title":"Requirement for NF-kappaB signalling in a mouse model of lung adenocarcinoma","volume":"462","author":"Meylan","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.lungcan.2013.10.018_bib0050","doi-asserted-by":"crossref","first-page":"3537","DOI":"10.1158\/0008-5472.CAN-09-4290","article-title":"Requirement of the NF-kappaB subunit p65\/RelA for K-Ras-induced lung tumorigenesis","volume":"70","author":"Basseres","year":"2010","journal-title":"Cancer Res"},{"key":"10.1016\/j.lungcan.2013.10.018_bib0055","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1038\/nrd2926","article-title":"Targeting the phosphoinositide 3-kinase pathway in cancer","volume":"8","author":"Liu","year":"2009","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.lungcan.2013.10.018_bib0060","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1200\/JCO.2009.25.3641","article-title":"The PI3K pathway as drug target in human cancer","volume":"28","author":"Courtney","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.lungcan.2013.10.018_bib0065","first-page":"535","article-title":"Oncogene addiction: sometimes a temporary slavery","volume":"6","author":"Jonkers","year":"2004","journal-title":"Cancer Cell"},{"key":"10.1016\/j.lungcan.2013.10.018_bib0070","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.bbrc.2008.08.148","article-title":"Identification of the RelA domain responsible for action of a new NF-kappaB inhibitor DHMEQ","volume":"376","author":"Watanabe","year":"2008","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.lungcan.2013.10.018_bib0075","doi-asserted-by":"crossref","first-page":"5780","DOI":"10.1021\/jm8006245","article-title":"Inactivation of NF-kappaB components by covalent binding of (-)-dehydroxymethylepoxyquinomicin to specific cysteine residues","volume":"51","author":"Yamamoto","year":"2008","journal-title":"J Med Chem"},{"key":"10.1016\/j.lungcan.2013.10.018_bib0080","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1093\/nar\/19.9.2499","article-title":"A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells","volume":"19","author":"Andrews","year":"1991","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.lungcan.2013.10.018_bib0085","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1038\/sj.leu.2404167","article-title":"DHMEQ, a new NF-kappaB inhibitor, induces apoptosis and enhances fludarabine effects on chronic lymphocytic leukemia cells","volume":"20","author":"Horie","year":"2006","journal-title":"Leukemia"},{"key":"10.1016\/j.lungcan.2013.10.018_bib0090","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0065-2571(84)90007-4","article-title":"Quantitative analysis of dose\u2013effect relationships: the combined effects of multiple drugs or enzyme inhibitors","volume":"22","author":"Chou","year":"1984","journal-title":"Adv Enzyme Regul"},{"key":"10.1016\/j.lungcan.2013.10.018_bib0095","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1016\/j.freeradbiomed.2011.09.029","article-title":"Inhibition of NF-kappaB and DNA double-strand break repair by DMAPT sensitizes non-small-cell lung cancers to X-rays","volume":"51","author":"Estabrook","year":"2011","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.lungcan.2013.10.018_bib0100","first-page":"354","article-title":"Sulindac enhances tumor necrosis factor-alpha-mediated apoptosis of lung cancer cell lines by inhibition of nuclear factor-kappaB","volume":"8","author":"Berman","year":"2002","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.lungcan.2013.10.018_bib0105","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1158\/1541-7786.MCR-08-0410","article-title":"Nuclear factor-kappaB inhibition by parthenolide potentiates the efficacy of Taxol in non-small cell lung cancer in vitro and in vivo","volume":"7","author":"Zhang","year":"2009","journal-title":"Mol Cancer Res"},{"key":"10.1016\/j.lungcan.2013.10.018_bib0110","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1158\/2159-8290.CD-11-0159","article-title":"Targeting NF-kappaB in mouse models of lung adenocarcinoma","volume":"1","author":"Van Waes","year":"2011","journal-title":"Cancer Discov"},{"key":"10.1016\/j.lungcan.2013.10.018_bib0115","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.cell.2006.01.016","article-title":"TOR signaling in growth and metabolism","volume":"124","author":"Wullschleger","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.lungcan.2013.10.018_bib0120","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1074\/jbc.M306976200","article-title":"Cell type-specific expression of the IkappaB kinases determines the significance of phosphatidylinositol 3-kinase\/Akt signaling to NF-kappa B activation","volume":"279","author":"Gustin","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.lungcan.2013.10.018_bib0125","doi-asserted-by":"crossref","first-page":"30935","DOI":"10.1074\/jbc.M201919200","article-title":"Phosphatidylinositol 3-kinase\/Akt stimulates androgen pathway through GSK3beta inhibition and nuclear beta-catenin accumulation","volume":"277","author":"Sharma","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.lungcan.2013.10.018_bib0130","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.cllc.2012.12.001","article-title":"Preclinical rationale for PI3K\/Akt\/mTOR pathway inhibitors as therapy for epidermal growth factor receptor inhibitor-resistant non-small-cell lung cancer","volume":"14","author":"Gadgeel","year":"2013","journal-title":"Clin Lung Cancer"},{"key":"10.1016\/j.lungcan.2013.10.018_bib0135","doi-asserted-by":"crossref","first-page":"2637","DOI":"10.1002\/cncr.22315","article-title":"Nuclear factor-kappaB (NF-kappaB) is frequently expressed in lung cancer and preneoplastic lesions","volume":"107","author":"Tang","year":"2006","journal-title":"Cancer"}],"container-title":["Lung Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500213004893?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500213004893?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,10]],"date-time":"2018-10-10T21:23:25Z","timestamp":1539206605000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169500213004893"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2]]},"references-count":27,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,2]]}},"alternative-id":["S0169500213004893"],"URL":"https:\/\/doi.org\/10.1016\/j.lungcan.2013.10.018","relation":{},"ISSN":["0169-5002"],"issn-type":[{"value":"0169-5002","type":"print"}],"subject":[],"published":{"date-parts":[[2014,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Activation of Akt involves resistance to NF-\u03baB inhibition and abrogation of both triggers synergistic apoptosis in lung adenocarcinoma cells","name":"articletitle","label":"Article Title"},{"value":"Lung Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lungcan.2013.10.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}